Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Plus Estramustine in Hormone Refractory Prostate Cancer
NCT00003717Phase 2Unknown
- Sponsor
- Cooperman Barnabas Medical Center
- Start
- Oct 1998
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel and estramustine in prostate cancer (PCa), sponsored by Cooperman Barnabas Medical Center. Primary endpoints: Objective Response Rate, Duration of Response and 1 more. Status: unknown.
02
Drugs
paclitaxelestramustine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003717.